150,000-200,000 children are born with SCD in Nigeria each year… 50% of them will not live to see their fifth birthday
Tackle Sickle Cell, The McCourty Twins – Devin (New England Patriots) and Jason (Miami Dolphins) – and the Brain and Body Foundation are joining forces to address the scourge of Sickle Cell Anaemia in Nigeria.
PLAN OF ATTACK
SICKLE CELL IN NIGERIA: OUR “ENDGAME”
TO REDUCE THE DEATH RATE OF CHILDREN BELOW THE
AGE OF 5 LIVING WITH SICKLE CELL DISEASE FROM 75% TO LESS THAN 10% BY 2025
2000 children for 12 months
The plan is to collaborate with the McCourty twins (Jason and Devin), Tackle Sickle Cell, and Embrace Kids Foundation to provide supplements for 2000 children in Nigeria for a duration of 12 months to help reduce crises and improve their quality of life.
These supplements will be a combination of Vitamin-C, Vitamin-D, and Zinc, which have all been proven to help strengthen the immune system and significantly improve the health of the cells in the body of these children.
SCD Research: Strong Immune System = Enhanced Quality of Life
Our goal is to drastically reduce the number of children dying each year, as a result of Sickle Cell Disorder (SCD). To achieve that, Doctors and Healthcare Professionals need to prescribe immune support supplements in addition to folic acid and anti-malaria.
Before they can do that, we must provide them with compelling evidence that immune system fortification is important in children with SCD, and that is why we need to do this research.
For more information click here
Education of the public on how to triumph with SCD
Through our social media platforms: Instagram, Facebook, and LinkedIn, our website, and via TV programs, we hope to continually provide parents of children with Sickle Cell Disorder with up-to-date research, the utmost best tips, and strategies to improve and maintain the lives of their children.
To watch our remarkable SCD testimonials, click here
Advocate for Change
From our work with the Nigerian Government, we hope to make all these strategies part of the main policies in the treatment of individuals with Sickle Cell Disorder for both children and adults.
For more information visit our advocacy page